Novartis Financial Results – Q3 2021

Novartis announced the company’s financial results for the third quarter of 2021.

Media contacts

Find contacts at Novartis for media and journalist inquiries from the general and individual contacts.

Narrow photography of a man using a tablet

Media library

Browse and download multimedia resources including images, videos, infographics and more.

Today, with @MolecularPrtnrs, we are excited to announce a positive top line data from a Phase 2 study for a #COVID19 antiviral treatment. Novartis will exercise its option to in-license this therapeutic candidate from Molecular Partners.  #NovartisNews

Novartis, Alnylam announce collaboration to discover and develop potential targeted therapy for patients with end-stage liver disease

Novartis receives FDA approval for new indications for the treatment of #EnthesitisRelatedArthritis and #PsoriaticArthritis in children and adolescents. #NovartisNews #ReimaginingMedicine

Latest news

Jan 10, 2022

Media Release

Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19

Jan 06, 2022

Media Update

Novartis announces collaboration with Alnylam to explore targeted therapy to restore liver function

Jan 04, 2022

Media Release

Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validity of Gilenya® (fingolimod) dosage regimen patent

All News

Stories

Our research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.

Novartis Annual Review 2020

The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2020.

A young girl sits at a health clinic in Sikasso, Mali.

Environmental, Social and Governance

Novartis aims to hold itself to the highest standards of sustainability and ethical business practices.

#NovartisNews

Tweets from the Media Relations team

Follow @NovartisNews

Transmission electron microscopic image of an isolate from a case of COVID-19

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Live Magazine

Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.

Novartis Gene Therapies Global Managed Access Program

Novartis Gene Therapies recommits to Global Managed Access Program for 2021 so that children around the world can benefit from SMA treatment who otherwise would not have access to Zolgensma.

Subscribe

Get the latest news and updates from Novartis directly to your inbox.

Learn More